178 related articles for article (PubMed ID: 16206233)
21. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.
Hanna Z; Priceputu E; Hu C; Vincent P; Jolicoeur P
Virology; 2006 Mar; 346(1):40-52. PubMed ID: 16310238
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 Nef impairs MHC class II antigen presentation and surface expression.
Stumptner-Cuvelette P; Morchoisne S; Dugast M; Le Gall S; Raposo G; Schwartz O; Benaroch P
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12144-9. PubMed ID: 11593029
[TBL] [Abstract][Full Text] [Related]
23. Biological roles of HIV Nef proteins. A minireview.
Cernescu C; Ruţă S
Rev Roum Virol; 1992; 43(1-2):95-100. PubMed ID: 1288645
[TBL] [Abstract][Full Text] [Related]
24. Endogenously expressed HIV-1 nef down-regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells.
Shinya E; Owaki A; Shimizu M; Takeuchi J; Kawashima T; Hidaka C; Satomi M; Watari E; Sugita M; Takahashi H
Virology; 2004 Aug; 326(1):79-89. PubMed ID: 15262497
[TBL] [Abstract][Full Text] [Related]
25. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
Buseyne F; Scott-Algara D; Corre B; Porrot F; Monchatre E; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
Virology; 2006 Oct; 354(2):271-9. PubMed ID: 16904156
[TBL] [Abstract][Full Text] [Related]
26. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
[TBL] [Abstract][Full Text] [Related]
27. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the SH3-binding region of HIV-1 nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket.
Craig HM; Pandori MW; Riggs NL; Richman DD; Guatelli JC
Virology; 1999 Sep; 262(1):55-63. PubMed ID: 10489340
[TBL] [Abstract][Full Text] [Related]
29. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.
Yang OO; Nguyen PT; Kalams SA; Dorfman T; Göttlinger HG; Stewart S; Chen IS; Threlkeld S; Walker BD
J Virol; 2002 Feb; 76(4):1626-31. PubMed ID: 11799157
[TBL] [Abstract][Full Text] [Related]
30. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.
Yang OO; Sarkis PT; Ali A; Harlow JD; Brander C; Kalams SA; Walker BD
J Exp Med; 2003 May; 197(10):1365-75. PubMed ID: 12743169
[TBL] [Abstract][Full Text] [Related]
31. Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses.
Specht A; DeGottardi MQ; Schindler M; Hahn B; Evans DT; Kirchhoff F
Virology; 2008 Mar; 373(1):229-37. PubMed ID: 18155264
[TBL] [Abstract][Full Text] [Related]
32. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
[TBL] [Abstract][Full Text] [Related]
33. The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC.
Riggs NL; Craig HM; Pandori MW; Guatelli JC
Virology; 1999 Jun; 258(2):203-7. PubMed ID: 10366557
[TBL] [Abstract][Full Text] [Related]
34. Cutting edge: induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen.
Tobery T; Siliciano RF
J Immunol; 1999 Jan; 162(2):639-42. PubMed ID: 9916680
[TBL] [Abstract][Full Text] [Related]
35. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.
Luzuriaga K; Holmes D; Hereema A; Wong J; Panicali DL; Sullivan JL
J Immunol; 1995 Jan; 154(1):433-43. PubMed ID: 7995957
[TBL] [Abstract][Full Text] [Related]
36. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein.
Robertson MN; Buseyne F; Schwartz O; Rivière Y
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1217-23. PubMed ID: 7511396
[TBL] [Abstract][Full Text] [Related]
37. Partial "repair" of defective NEF genes in a long-term nonprogressor with human immunodeficiency virus type 1 infection.
Carl S; Daniels R; Iafrate AJ; Easterbrook P; Greenough TC; Skowronski J; Kirchhoff F
J Infect Dis; 2000 Jan; 181(1):132-40. PubMed ID: 10608759
[TBL] [Abstract][Full Text] [Related]
38. Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL.
Motozono C; Yanaka S; Tsumoto K; Takiguchi M; Ueno T
J Immunol; 2009 May; 182(9):5528-36. PubMed ID: 19380801
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
[TBL] [Abstract][Full Text] [Related]
40. Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.
Lewis MJ; Lee P; Ng HL; Yang OO
J Virol; 2012 Jul; 86(13):7126-35. PubMed ID: 22553319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
